Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Metronidazole- and Tinidazole-Based Bismuth Quadruple Regimens for Helicobacter Pylori Eradication
NCT07746934Not yet recruiting
- Sponsor
- University of Medicine and Pharmacy of Ho Chi Minh City
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of tinidazole in Helicobacter pylori infection (2 arms), sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Primary endpoint: Helicobacter pylori Eradication Rate. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
tinidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07746934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746934.